About C.I.C. Mauricie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Pfizer
4
Merck Sharp & Dohme LLC
2
Regeneron Pharmaceuticals
1
Verona Pharma plc
1
Clinical Trials at C.I.C. Mauricie
During the past decade, C.I.C. Mauricie conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on
average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus
2006-03-06
2008-02-19
Terminated
354
Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma
2007-02-01
2008-08-01
Completed
159
A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
2013-07-31
2017-01-02
Completed
1,081
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
2014-10-28
2017-07-10
Completed
746
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
2016-09-20
2019-07-26
Completed
517
A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-027)
2018-03-14
2020-08-17
Completed
732
A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)
2018-03-15
2020-10-30
Completed
1,317
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "C.I.C. Mauricie" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Pfizer" with 4 trials
sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Regeneron Pharmaceuticals" with 1 trials sponsored and "Verona Pharma plc"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "C.I.C. Mauricie"
#1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at C.I.C. Mauricie
According to Clinical.Site data, the most researched conditions in "C.I.C. Mauricie" are
"Asthma" (3 trials), "Chronic Cough" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Allergic Rhinitis Due to Cat Allergy" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "C.I.C. Mauricie" in a lesser frequency.
Clinical Trials Intervention Types at C.I.C. Mauricie
Most popular intervention types in "C.I.C. Mauricie" are "Drug" (11 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Bococizumab (PF-04950615; RN316)" (1 trials), "Ensifentrine" (1 trials) and "Gefapixant" (1 trials). Other intervention names were less common.
Clinical Trials Genders at C.I.C. Mauricie
The vast majority of trials in "C.I.C. Mauricie" are
12 trials for "All" genders.
Clinical Trials Status at C.I.C. Mauricie
Currently, there are NaN active trials in "C.I.C. Mauricie".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in C.I.C. Mauricie,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in C.I.C. Mauricie, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".